Ribozymes are RNA molecules that possess the ability to cleave and thus des
troy other RNA molecules. As a result of this ability, they are ideal speci
fic agents to use against the messenger RNAs of important genes found to be
linked with disease (of cellular and viral origin). This review will brief
ly describe the different types of ribozyme and the potential they have as
therapeutic compounds against viruses, oncogenes and drug resistance in hae
matological settings. The latest news from the various Phase I and II riboz
yme clinical trials is discussed, as is the potential for the ribozymes' fu
ture as therapeutic agents.